Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application

Area of Science:

• Cardiovascular Medicine
• Inflammation Research
• Translational Science

Background:

• Atherosclerosis is the primary global cause of mortality.
• It is increasingly understood as an inflammatory disease of the arterial wall.
• Despite this knowledge, clinical applications remain limited.

Purpose of the Study:

• To review potential molecular inflammatory targets for atherosclerosis.
• To summarize ongoing clinical trials targeting inflammatory processes in cardiovascular disease.
• To highlight the gap in translational science for atherosclerosis treatment.

Main Methods:

• Literature review of basic science research on inflammatory targets.
• Analysis of ongoing clinical trials investigating anti-inflammatory therapies.
• Synthesis of findings to assess translational success.

Main Results:

• Several molecular inflammatory targets show clinical relevance.
• Ongoing trials are evaluating anti-inflammatory strategies for cardiovascular events.
• The translation of basic science findings into clinical practice for atherosclerosis has been limited.

Conclusions:

• Targeting specific inflammatory pathways holds promise for novel atherosclerosis therapies.
• Enhanced translational science efforts are crucial for improving patient outcomes.
• Future research should focus on bridging the gap between basic science and clinical application in atherosclerosis management.